Flagship Pioneering, LLC reported 7 holdings worth US$1.96B as of Sep 30, 2026 (Form 13F)
As of Sep 30, 2026 · Filed Nov 16, 2026
Flagship Pioneering, LLC reported 7 holdings worth US$1.96B as of Sep 30, 2026. Largest: Generate Biomedicines, Inc., Moderna, Inc. and Sana Biotechnology, Inc. Filed Nov 16, 2026 (Form 13F).
- Holdings
- 7
- Value as reported
- US$1.96B
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Generate Biomedicines, Inc. | 62.7M | US$941M | 48.1% |
| Moderna, Inc. | 4.63M | US$892M | 45.6% |
| Sana Biotechnology, Inc. | 25M | US$72.9M | 3.7% |
| Foghorn Therapeutics Inc. | 12.7M | US$45.2M | 2.3% |
| Seres Therapeutics, Inc. | 1.16M | US$3.87M | 0.20% |
Source
Download original · View original at SEC